AtriCure (ATRC) Assets (2010 - 2026)

AtriCure (ATRC) has reported Assets for 17 consecutive years, with $676.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets rose 11.13% year-over-year to $676.6 million in Q2 2026; TTM through Jun 2026 was $676.6 million, a 11.13% increase from a year earlier, with the FY2025 full-year figure at $654.2 million, up 7.36% from the prior year.
• Assets was $676.6 million for Q2 2026 at AtriCure, up from $644.0 million in the prior quarter.
• Over five years, Assets peaked at $676.6 million in Q2 2026 and troughed at $581.9 million in Q3 2022.
• A 5-year average of $608.6 million and a median of $598.8 million in 2023 frame the typical range for Assets.
• Across the five-year window, Assets retreated 16.42% in 2022 and increased 11.13% in 2026, its largest moves.
• Over 5 years, Assets stood at $585.4 million in 2022, then gained by 4.87% to $613.9 million in 2023, then decreased by 0.75% to $609.3 million in 2024, then gained by 7.36% to $654.2 million in 2025, then advanced by 3.43% to $676.6 million in 2026.
• The last three Assets figures came in at $676.6 million (Q2 2026), $644.0 million (Q1 2026), and $654.2 million (Q4 2025), per Business Quant data.